Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Impact of Circadian Rhythm on Anti-PD-1/PD-L1 Immunotherapy

NCT07224971 is registered in ClinicalTrials.gov with Liza Villaruz, MD as lead sponsor.

NCT NCT07224971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07224971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Impact of Circadian Rhythm on Anti-PD-1/PD-L1 Immunotherapy
Lead sponsor
Liza Villaruz, MD
Phase
Phase 2
Overall status
Recruiting
Start date
December 2, 2025
Completion date
May 1, 2030
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced/metastatic nsclc